Ventilation Heterogeneity and Its Association with Nodule Formation Among Participants in the National Lung Screening Trial-A Preliminary Investigation
- PMID: 31471206
- PMCID: PMC7243969
- DOI: 10.1016/j.acra.2019.07.024
Ventilation Heterogeneity and Its Association with Nodule Formation Among Participants in the National Lung Screening Trial-A Preliminary Investigation
Abstract
Rationale and objectives: We have developed a technique to measure ventilation heterogeneity (VH) on low dose chest CT scan that we hypothesize may be associated with the development of lung nodules, and perhaps cancer. If true, such an analysis may improve screening by identifying regional areas of higher risk.
Materials and methods: Using the National Lung Screening Trial database, we identified a small subset of those participants who were labeled as having a positive screening test at 1 year (T1) but not at baseline (T0). We isolated the region in which the nodule would form on the T0 scan ("target region") and measured VH as the standard deviation of the linear dimension of a virtual cubic airspace based on measurement of lung attenuation within the region.
Results: We analyzed 24 cases, 9 with lung cancer and 15 with a benign nodule. We found that the VH of the target region was nearly statistically greater than that of the corresponding contralateral control region (0.168 [0.110-0.226] vs. 0.112 [0.083-0.203], p = 0.051). The % emphysema within the target region was greater than that of the corresponding contralateral control region (1.339 [0.264-4.367] vs. 1.092 [0.375-4.748], p = 0.037). There was a significant correlation between the % emphysema and the VH of the target region (rho = +0.437, p = 0.026).
Conclusion: Our study provides the first data in support of increased local VH being associated with subsequent lung nodule formation. Further work is necessary to determine whether this technique can enhance screening for lung cancer by low dose chest CT scan.
Keywords: Linear airspace dimension; Low dose chest CT; Lung cancer; National Lung Screening Trial; Ventilation heterogeneity.
Copyright © 2019 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.Clin Lung Cancer. 2018 Mar;19(2):148-156.e3. doi: 10.1016/j.cllc.2017.10.002. Epub 2017 Oct 13. Clin Lung Cancer. 2018. PMID: 29137847 Free PMC article.
-
Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.Lung Cancer. 2018 Nov;125:103-108. doi: 10.1016/j.lungcan.2018.05.007. Epub 2018 May 14. Lung Cancer. 2018. PMID: 30429006 Clinical Trial.
-
Malignancy risk estimation of screen-detected nodules at baseline CT: comparison of the PanCan model, Lung-RADS and NCCN guidelines.Eur Radiol. 2017 Oct;27(10):4019-4029. doi: 10.1007/s00330-017-4767-2. Epub 2017 Mar 14. Eur Radiol. 2017. PMID: 28293773 Free PMC article.
-
Lung Cancer Screening in the Community Setting.Ann Thorac Surg. 2018 Jun;105(6):1627-1632. doi: 10.1016/j.athoracsur.2018.01.075. Epub 2018 Mar 1. Ann Thorac Surg. 2018. PMID: 29501646 Review.
-
Lung Cancer Screening: Why, When, and How?Radiol Clin North Am. 2017 Nov;55(6):1163-1181. doi: 10.1016/j.rcl.2017.06.003. Radiol Clin North Am. 2017. PMID: 28991558 Review.
References
-
- American Cancer Society AC. Lung Cancer. 2019. Available from: http://www.cancer.org/cancer/lungcancer/.
-
- Gill R, Jaklitsch M, Jacobson F. Controversies in lung cancer screening. JAm Coll Radiol 2013; 10:931–936. - PubMed
-
- Nanavaty P, Alvarez M, Alberts W. Lung cancer screening: advantages, controversies, and applications. Cancer Control 2014; 21:9–14. - PubMed